Why an FDA Panel Had Concerns About Merck's COVID-19 Pill

Why an FDA Panel Had Concerns About Merck's COVID-19 Pill

Submitted by admin on December 11, 2021 - 9:26pm
Source: 
Motley Fool
News Tags: 
Merck
COVID-19
FDA
molnupiravir
Headline: 
Why an FDA Panel Had Concerns About Merck's COVID-19 Pill
snippet: 
  • An FDA panel voted 13-10 in favor of the risk-benefit of Merck's COVID-19 pill molnupiravir.
  • Committee members expressed concern that the drug could cause mutations in patients' DNA.
  • The lower efficacy for the drug than initially reported also likely influenced the committee's vote.

Do Not Allow Advertisers to Use My Personal information